Differentiation, evaluation, and application of human induced pluripotent stem cell–derived endothelial cells

Y Lin, CH Gil, MC Yoder - Arteriosclerosis, thrombosis, and …, 2017 - Am Heart Assoc
The emergence of induced pluripotent stem cell (iPSC) technology paves the way to
generate large numbers of patient-specific endothelial cells (ECs) that can be potentially …

Therapeutic potential of endothelial colony-forming cells in ischemic disease: strategies to improve their regenerative efficacy

P Faris, S Negri, A Perna, V Rosti, G Guerra… - International journal of …, 2020 - mdpi.com
Cardiovascular disease (CVD) comprises a range of major clinical cardiac and circulatory
diseases, which produce immense health and economic burdens worldwide. Currently …

Contributions of nonhuman primates to research on aging

ES Didier, AG MacLean, M Mohan… - Veterinary …, 2016 - journals.sagepub.com
Aging is the biological process of declining physiologic function associated with increasing
mortality rate during advancing age. Humans and higher nonhuman primates exhibit …

Scarring, stem cells, scaffolds and skin repair

D Markeson, JM Pleat, JR Sharpe… - Journal of tissue …, 2015 - Wiley Online Library
The treatment of full thickness skin loss, which can be extensive in the case of large burns,
continues to represent a challenging clinical entity. This is due to an on‐going inability to …

Therapeutic potential of endothelial progenitor cells in pulmonary diseases

OA Kolesnichenko, JA Whitsett, TV Kalin… - American Journal of …, 2021 - atsjournals.org
Compromised alveolar development and pulmonary vascular remodeling are hallmarks of
pediatric lung diseases such as bronchopulmonary dysplasia (BPD) and alveolar capillary …

Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers …

CR Cogle, E Wise, AM Meacham, C Zierold… - Circulation …, 2014 - Am Heart Assoc
Rationale: Bone marrow (BM) cell therapy for ischemic heart disease (IHD) has shown
mixed results. Before the full potency of BM cell therapy can be realized, it is essential to …

The vasoreparative potential of endothelial colony forming cells: a journey through pre-clinical studies

CL O'Neill, KJ McLoughlin, SEJ Chambers… - Frontiers in …, 2018 - frontiersin.org
For over a decade various cell populations have been investigated for their vasoreparative
potential. Cells with the capacity to promote blood vessel regeneration are commonly known …

Renal tissue engineering with decellularized rhesus monkey kidneys: age-related differences

KH Nakayama, CA Batchelder, CI Lee… - … Engineering Part A, 2011 - liebertpub.com
New therapies for severely damaged kidneys are needed due to limited regenerative
capacity and organ donor shortages. The goal of this study was to repopulate decellularized …

miR-193a-3p interaction with HMGB1 downregulates human endothelial cell proliferation and migration

CP Khoo, MG Roubelakis, JB Schrader, G Tsaknakis… - Scientific reports, 2017 - nature.com
Circulating endothelial colony forming cells (ECFCs) contribute to vascular repair where
they are a target for therapy. Since ECFC proliferative potential is increased in cord versus …

Growth differentiation factor 11 supports migration and sprouting of endothelial progenitor cells

G Finkenzeller, GB Stark, S Strassburg - Journal of Surgical Research, 2015 - Elsevier
Background Neovascularization plays an important role in tissue engineering applications.
In animal models, it was demonstrated that implantation of endothelial progenitor cells …